Cargando…
Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort
BACKGROUND: The natural history of prostate cancer is highly variable and it is difficult to predict. We showed previously that a cell cycle progression (CCP) score was a robust predictor of outcome in a conservatively managed cohort diagnosed by transurethral resection of the prostate. A greater ne...
Autores principales: | Cuzick, J, Berney, D M, Fisher, G, Mesher, D, Møller, H, Reid, J E, Perry, M, Park, J, Younus, A, Gutin, A, Foster, C S, Scardino, P, Lanchbury, J S, Stone, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304411/ https://www.ncbi.nlm.nih.gov/pubmed/22361632 http://dx.doi.org/10.1038/bjc.2012.39 |
Ejemplares similares
-
Validation of an RNA cell cycle progression score for predicting death from prostate cancer in a conservatively managed needle biopsy cohort
por: Cuzick, J, et al.
Publicado: (2015) -
Prognostic value of PTEN loss in men with conservatively managed localised prostate cancer
por: Cuzick, J, et al.
Publicado: (2013) -
Prognostic value of Ki-67 for prostate cancer death in a conservatively managed cohort
por: Fisher, G, et al.
Publicado: (2013) -
Long-term outcome among men with conservatively treated localised prostate cancer
por: Cuzick, J, et al.
Publicado: (2006) -
Validation of the cell cycle progression score to differentiate indolent from aggressive prostate cancer in men diagnosed through transurethral resection of the prostate biopsy
por: Cuzick, Jack M., et al.
Publicado: (2021)